Title: Sequential Transarterial Chemoembolization and Early Radiofrequency Ablation
Improves Clinical Outcomes for Early-intermediate Hepatocellular Carcinoma in a 10-year
Single-center Comparative Study
Version: 7 Date: 18 Feb 2021
Reviewer's report:
This article is dedicated to exploring the impact of the timing of TACE and RFA combined
therapy on the long-term efficacy of hepatocellular carcinoma patients, including overall
survival, tumor progression time, tumor response rate, and major complication rates. In this
article, HCC patients treated with initial TACE combined with RFA are apt to obtain long-term
survival. Even though the sample size of the study is limited, it also provides clinical evidence
for the timing of treatment for HCC patients, which is innovative.
Title: Sequential Transarterial Chemoembolization and Early Radiofrequency Ablation
Improves Clinical Outcomes for Early-intermediate Hepatocellular Carcinoma in a 10-year
Single-center Comparative Study
Version: 7 Date: 18 Feb 2021
Reviewer's report:
This article is dedicated to exploring the impact of the timing of TACE and RFA combined
therapy on the long-term efficacy of hepatocellular carcinoma patients, including overall
survival, tumor progression time, tumor response rate, and major complication rates. In this
article, HCC patients treated with initial TACE combined with RFA are apt to obtain long-term
survival. Even though the sample size of the study is limited, it also provides clinical evidence
for the timing of treatment for HCC patients, which is innovative.
Please review this paper.
user
Title: Sequential Transarterial Chemoembolization and Early Radiofrequency Ablation
Improves Clinical Outcomes for Early-intermediate Hepatocellular Carcinoma in a 10-year
Single-center Comparative Study
Version: 7 Date: 18 Feb 2021
Reviewer's report:
This article is dedicated to exploring the impact of the timing of TACE and RFA combined
therapy on the long-term efficacy of hepatocellular carcinoma patients, including overall
survival, tumor progression time, tumor response rate, and major complication rates. In this
article, HCC patients treated with initial TACE combined with RFA are apt to obtain long-term
survival. Even though the sample size of the study is limited, it also provides clinical evidence
for the timing of treatment for HCC patients, which is innovative.
assistant